18.12.2012 Views

Myeloid Leukemia

Myeloid Leukemia

Myeloid Leukemia

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Quantitative PCR for Monitoring CML Patients 87<br />

Table 1<br />

The Inter-Assay Variation of Threshold Cycle (Ct) Values for<br />

the Six b3a2 BCR-ABL Standards Measured Over 2 Yr (n =<br />

134) and Using a Threshold of 0.04<br />

Copy number Mean standard 2 standard Coefficient of<br />

of standards Ct value deviation range variation (%)<br />

15 36.45 35.36–37.54 1.50%<br />

1.5 × 10 2 33.01 32.35–33.67 1.00%<br />

1.5 × 10 3 29.53 28.90–30.16 1.06%<br />

1.5 × 10 4 26.12 25.61–26.63 0.98%<br />

1.5 × 10 5 22.75 22.20–23.30 1.21%<br />

1.5 × 10 6 19.37 18.96–19.78 1.05%<br />

samples in duplicate apart from the lowest standard, as a result of the wider variability<br />

at high threshold cycle (Ct) levels. The inter-assay reproducibility of the<br />

standard values is usually within 1.3 Ct, except for the lowest standard (see Table 1).<br />

The 2 standard deviation range provides an estimate of measurement reliability<br />

of the Ct values at approx the 95% level of confidence. The patient and control<br />

results are calculated from the standard curve and printed on the experiment<br />

report. Before accepting the results, the fluorescent curve of each control and<br />

patient sample must be viewed to ensure that the curve is linear and therefore<br />

acceptable. For some patients with BCR-ABL values that are not detectable, the<br />

background fluorescence may “creep” above the threshold. If this occurs, the<br />

quantitative value will be calculated from the fractional Ct value at the point it<br />

crosses the threshold. Therefore, a very high quantitative value will be assigned<br />

instead of a negative value. These samples must be noted and the correct value<br />

assigned on the experiment report. The HeLa negative control does on occasion<br />

produce a positive value that is less than 10 copies, in which case it is assigned as<br />

not detected. Patient values that are below this level are also assigned as not<br />

detected. If the negative control is greater than 10 copies, contamination may have<br />

occurred, and the samples are repeated. If the contamination represents only a very<br />

small number of copies, it will not influence the result of patients with values that<br />

are greater than 2 logs higher, and these samples need not be repeated. We have<br />

identified what appears to be a software error for the no-template control result. If<br />

these samples are assigned as “NTC” during sample setup, the result will always be<br />

printed as zero on the experiment report even for positive values (see arrows in Fig.<br />

3). Therefore, the no-template control fluorescence data must be viewed to ensure<br />

that it is actually negative. The BCR control transcript value provides an indication<br />

of the quality of the RNA. Values range from 30,000 to greater than 300,000 transcripts<br />

per 2.5 µL of cDNA for acceptable quality. Below 30,000 transcripts, the<br />

RNA is considered degraded and a repeat sample is requested. The RQ-PCR procedure,<br />

including processing the RNA extraction batch, the reverse transcription PCR,

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!